Associate Director/Director, Medical Affairs – Publications

The posting, as Braveheart Bio wrote it

About us

Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity.

With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area.

The role

Position reports to the Head of Medical Affairs. This individual will own the publications function for BHB-1893, leading the strategy, planning, and execution of a multi-year publication and congress plan that builds the body of evidence supporting the global development and future launch of BHB-1893 for obstructive and non-obstructive hypertrophic cardiomyopathy (oHCM and nHCM). This is a highly cross-functional and hands-on role that will serve as the central point of coordination for the publications strategy and execution. The individual will drive publications from concept through submission and publication, ensuring alignment, scientific quality, and timely delivery across the portfolio. This role will also be responsible for medical affairs reactive scientific communications supporting the global development and future launch of BHB-1893 for hypertrophic cardiomyopathy (HCM). All activities will reflect the highest standards of scientific integrity and remain fully compliant with GPP, ICMJE, and applicable regulatory and industry guidelines.

Key responsibilities

Publication strategy & planning

• Develop, own, and maintain the integrated strategic publication plan (including congress disclosures)
• Identify and prioritize publication opportunities across the full evidence lifecycle: clinical (Phase 1–3, long-term extension, subgroup, and pooled analyses), clinical pharmacology (PK/PD, PopPK, DDI, ethno-bridging), nonclinical/mechanistic, HEOR, disease-state and review articles, and real-world evidence.
• Define journal and congress targeting strategies, including late-breaking submissions and simultaneous publications timed with major data presentations.
• Maintain a backlog of future publication concepts and track emerging data to ensure no key dataset goes unpublished.

Congress & data dissemination

• Lead abstract, poster, oral presentation, and manuscript development for major cardiovascular and HCM congresses (e.g., ACC, AHA, ESC, ESC-HFA, HCMS, CVCT, HCM Summit) and relevant specialty meetings.
• Manage submission calendars and deadlines, ensuring

[…]
ls, with the ability to translate complex data into clear, compelling communications.

• Experience managing external agencies, authors, and budgets to deliver projects on time and on budget.
• Excellent organizational and project management skills with the ability to manage multiple concurrent deliverables and deadlines.
• Ability to work independently and collaboratively in a fast-moving, resource-lean environment and remain comfortable with change and ambiguity.
• Flexible, proactive, and hands-on mindset with a roll-up-your-sleeves, can-do attitude
• Ability to travel domestically and internationally (approximately 15–20%), including to major congresses.

Preferred experience & skills

• Background or publication experience in cardiovascular medicine, ideally HCM, heart failure, or cardiac myosin inhibitors
• Certified Medical Publication Professional (CMPP) certification
• Experience with late-breaking clinical trial presentations and simultaneous publications
• Experience with global publications involving ex-US or licensing partners, particularly China-generated data
• Experience building a publications function or processes at a small-to-mid-size biotech
• Familiarity with HEOR/RWE publications and clinical pharmacology data
• Hands-on experience with publication management platforms

Base Salary Range: $175,000 - $245,000

This role is also eligible for a competitive total rewards package, which may include an annual bonus, equity, and a comprehensive benefits offering.

We are an equal opportunity employer.

We are committed to inclusion and diversity, and we do not discriminate on the basis of race, gender, religion, gender, sexual orientation, age, color, marital status, veteran status, disability status, national origin, or any characteristic protected under applicable law.

Braveheart participates in the federal E ‑ Verify program to confirm employment authorization for all new hires.

To learn more about E-Verify please review this poster .